March 02, 2015 10:31 AM ET

Life Sciences Tools and Services

Company Overview of Clinipace Worldwide, Inc.

Company Overview

Clinipace Worldwide, Inc. provides digital contract research solutions to pharmaceutical, biotechnology, and medical device companies. It offers clinical research, strategic product development, clinical development, regulatory, GxP/chemistry, manufacturing, and control (CMC)/quality assurance, and post-approval services in various therapeutic areas, such as cardiovascular and metabolic diseases, central nervous system, dermatology, gastroenterology, immunology, infectious diseases, nephrology, oncology, respiratory, rheumatology, and vaccines (and other cell and tissue based therapies). The company also provides biostatistics, clinical monitoring, data management, good clinical practice tra...

3800 Paramount Parkway

Suite 100

Morrisville, NC 27560

United States

Founded in 2003





Key Executives for Clinipace Worldwide, Inc.

Co-Founder, Chief Executive Officer and Director
Co-Founder, President and General Counsel
Chief Financial Officer
Chief Operating Officer
Chief Executive Officer of European Operations
Compensation as of Fiscal Year 2014.

Clinipace Worldwide, Inc. Key Developments

Clinipace Worldwide Appoints Fred B. Davenport, Jr. to its Board of Directors

Clinipace Worldwide announced the addition of Fred B. Davenport, Jr., to its Board of Directors. As an independent director, Fred brings to Clinipace a significant pedigree in scaling global organizations within the CRO industry, having spent 10 years at Pharmaceutical Product Development, Inc.

Roger Morgan Joins Clinipace Worldwide, Inc. as Executive Vice President, Global Medical Affairs

Clinipace Worldwide, Inc. announced the addition of Dr. Roger Morgan, MD, FACS, as Executive Vice President, Global Medical Affairs. Dr. Morgan has experience in global medical affairs with both pharmaceutical companies and CROs. While trained as a surgeon/critical care intensivist, he spent much of his industry career focused on cardiovascular research. Dr. Morgan provides oversight and leadership for the global Medical Affairs department, including the cardiometabolic team, medical monitoring, and the pharmacovigilance/safety groups. His responsibilities also include providing senior medical/safety oversight of clinical trials to ensure standard operating procedures, sponsor directives, and patient safety regulatory requirements are followed. In addition, Dr. Morgan will be a resource for the Regulatory and Strategic Development, Business Development, Clinical Operations, and Informatics teams. Prior to Clinipace, Dr. Morgan served as the Medical Director, then Chief Medical Officer at Kowa Research Institute, where he worked on multiple cardiovascular, endocrine, ophthalmologic, and other therapeutic programs, and evaluated multiple preclinical molecules and potential in-licensing candidates in these areas.

Karyopharm Therapeutics Signs Preferred Provider Agreement with Clinipace Worldwide

Karyopharm Therapeutics revealed the execution of a preferred provider agreement to manage several clinical programmes, including oncology, wound healing and other diseases in partnership with Clinipace Worldwide. Under the long-term strategic partnership, Clinipace expects to manage numerous study starts on behalf of Karyopharm in 2014.

Similar Private Companies By Industry

Company Name Region
MedCatheters LLC United States
Pharma Trials International, LLC United States
PanGenX, Inc. United States
Protein Forest, Inc. United States
BTG International Inc. United States

Recent Private Companies Transactions

Private Placement
January 2, 2015
March 11, 2014
Choice Pharma (HK) Limited

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Clinipace Worldwide, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at